Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gil Reynolds Diogo & Rajko Reljic. (2014) Development of a New Tuberculosis Vaccine: Is there Value in the Mucosal Approach?. Immunotherapy 6:9, pages 1001-1013.
Read now
Read now
Corinne SC Merle, Sergio S Cunha & Laura C Rodrigues. (2010) BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Review of Vaccines 9:2, pages 209-222.
Read now
Read now
James A Triccas & Jonathan K Nambiar. (2009) Challenge of developing new tuberculosis vaccines to generate life-long protective immunity. Expert Review of Vaccines 8:7, pages 823-825.
Read now
Read now
Kornelija Mise, Ivana Goic‐Barisic, Anteo Bradaric, Marija Tonkic, Neven Vrsalović & Jakica Karanovic. (2008) Long‐term course and treatment of a cutaneous BCG infection. Journal of Dermatological Treatment 19:6, pages 333-336.
Read now
Read now
Michael J Brennan, Sheldon L Morris & Christine F Sizemore. (2004) Tuberculosis vaccine development: research, regulatory and clinical strategies. Expert Opinion on Biological Therapy 4:9, pages 1493-1504.
Read now
Read now
Articles from other publishers (82)
Xiaoyan Cui & Ya-Ting Wang. (2024) Function of autophagy genes in innate immune defense against mucosal pathogens. Current Opinion in Microbiology 79, pages 102456.
Crossref
Crossref
Mieko Tokano, Norihito Tarumoto, Kazuo Imai, Takuya Sekine, Yasuto Omura, Kosuke Uehara & Shigefumi Maesaki. (2024) Acute tenosynovitis following an accidental injection of Bacille Calmette-Guérin (BCG) in a health care worker: A case report. Infection Prevention in Practice 6:1, pages 100332.
Crossref
Crossref
Leonardo Martinez, Olivia Cords, Qiao Liu, Carlos Acuna-Villaorduna, Maryline Bonnet, Greg J Fox, Anna Cristina C Carvalho, Pei-Chun Chan, Julio Croda, Philip C Hill, Elisa Lopez-Varela, Simon Donkor, Katherine Fielding, Stephen M Graham, Marcos A Espinal, Beate Kampmann, Arthur Reingold, Helena Huerga, Julian A Villalba, Louis Grandjean, Giovanni Sotgiu, Uzochukwu Egere, Sarman Singh, Limei Zhu, Christian Lienhardt, Justin T Denholm, James A Seddon, Christopher C Whalen, Alberto L García-Basteiro, Rina Triasih, Cheng Chen, Jitendra Singh, Li-Min Huang, Surendra Sharma, Djohar Hannoun, Helena del Corral, Anna M Mandalakas, LaShaunda L Malone, Du-Lin Ling, Afrânio Kritski, Catherine M Stein, Richa Vashishtha, Fadila Boulahbal, Chi-Tai Fang, W Henry Boom, Eduardo Martins Netto, Antonio Carlos Lemos, Anneke C Hesseling, Alexander Kay, Edward C Jones-López, C Robert Horsburgh, Christoph Lange & Jason R Andrews. (2022) Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. The Lancet Global Health 10:9, pages e1307-e1316.
Crossref
Crossref
Gopichand Gutti, Karan Arya & Sushil Kumar Singh. (2019) Latent Tuberculosis Infection (LTBI) and Its Potential Targets: An Investigation into Dormant Phase Pathogens. Mini-Reviews in Medicinal Chemistry 19:19, pages 1627-1642.
Crossref
Crossref
Diego G. Módolo, Cynthia S. Horn, José S. M. Soares, José A. Yunes, Leila M. Lima, Sylvia M. de Sousa & Marcelo Menossi. (2018) Transgenic Nicotiana tabacum seeds expressing the Mycobacterium tuberculosis Alanine- and Proline-rich antigen. AMB Express 8:1.
Crossref
Crossref
Manuela Flórido, Heni Muflihah, Leon C.W. Lin, Yingju Xia, Frederic Sierro, Mainthan Palendira, Carl G. Feng, Patrick Bertolino, John Stambas, James A. Triccas & Warwick. J. Britton. (2018) Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis. Mucosal Immunology 11:6, pages 1743-1752.
Crossref
Crossref
Amy L. Yang, Thomas E. Schmidt, Scott Stibitz, Steven C. Derrick, Sheldon L. Morris & Marcela Parra. (2016) A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system. Journal of Microbiological Methods 131, pages 7-9.
Crossref
Crossref
Steven C. Derrick, Idalia Yabe, Sheldon Morris & Siobhan Cowley. (2016) Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice. Clinical and Vaccine Immunology 23:7, pages 638-647.
Crossref
Crossref
Robin Lombard, Emilie Doz, Florence Carreras, Mathieu Epardaud, Yves Le Vern, Dominique Buzoni-Gatel & Nathalie Winter. (2016) IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response. PLOS ONE 11:2, pages e0149455.
Crossref
Crossref
Mateo Zuluaga G. (2015) ¿Reinfección o reactivación en la tuberculosis pulmonar? Un reto diagnóstico. Revista Facultad Nacional de Salud Pública 33:3.
Crossref
Crossref
Juan I. Moliva, Joanne Turner & Jordi B. Torrelles. (2015) Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: Why does BCG fail to protect against tuberculosis?. Vaccine 33:39, pages 5035-5041.
Crossref
Crossref
Isabelle C. Arnold, Claire Hutchings, Ivanela Kondova, Ariann Hey, Fiona Powrie, Peter Beverley & Elma Tchilian. (2015) Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis. Vaccine 33:15, pages 1808-1814.
Crossref
Crossref
Joan M. Mangan, Sebastian Galindo-Gonzalez & Tracy A. Irani. (2013) Development and Initial Testing of Messages to Encourage Tuberculosis Testing and Treatment Among Bacille Calmette-Guerin (BCG) Vaccinated Persons. Journal of Immigrant and Minority Health 17:1, pages 79-88.
Crossref
Crossref
Michael Oluyemi Babalola. (2015) The Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of <i>Mycobacterium tuberculosis</i>: A Systematic Review. Journal of Tuberculosis Research 03:04, pages 184-205.
Crossref
Crossref
Steven C. Derrick, Amy Yang, Marcela Parra, Kristopher Kolibab & Sheldon L. Morris. (2015) Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice. Vaccine 33:1, pages 126-132.
Crossref
Crossref
K. Kolibab, A. Yang, M. Parra, S. C. Derrick & S. L. Morris. (2014) Time to Detection of Mycobacterium tuberculosis Using the MGIT 320 System Correlates with Colony Counting in Preclinical Testing of New Vaccines. Clinical and Vaccine Immunology 21:3, pages 453-455.
Crossref
Crossref
Emilie Doz, Robin Lombard, Florence Carreras, Dominique Buzoni-Gatel & Nathalie Winter. (2013) Mycobacteria-Infected Dendritic Cells Attract Neutrophils That Produce IL-10 and Specifically Shut Down Th17 CD4 T Cells through Their IL-10 Receptor. The Journal of Immunology 191:7, pages 3818-3826.
Crossref
Crossref
Riva Kovjazin, David Shitrit, Rachel Preiss, Ilanit Haim, Lev Triezer, Leonardo Fuks, Abdel Rahman Nader, Meir Raz, Ritta Bardenstein, Galit Horn, Nechama I. Smorodinsky & Lior Carmon. (2013) Characterization of Novel Multiantigenic Vaccine Candidates with Pan-HLA Coverage against Mycobacterium tuberculosis. Clinical and Vaccine Immunology 20:3, pages 328-340.
Crossref
Crossref
Kim Connelly Smith, Ian M. Orme & Jeffrey R. Starke. 2013. Vaccines. Vaccines
789
811
.
Ted Cohen, Paul D. van Helden, Douglas Wilson, Caroline Colijn, Megan M. McLaughlin, Ibrahim Abubakar & Robin M. Warren. (2012) Mixed-Strain Mycobacterium tuberculosis Infections and the Implications for Tuberculosis Treatment and Control. Clinical Microbiology Reviews 25:4, pages 708-719.
Crossref
Crossref
Ankan Gupta, F.J. Ahmad, Faiz Ahmad, U.D. Gupta, M. Natarajan, V.M. Katoch & Sangeeta Bhaskar. (2012) Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model. Vaccine 30:43, pages 6198-6209.
Crossref
Crossref
Wasiulla Rafi, Rodrigo Ribeiro-Rodrigues, Jerrold J. Ellner & Padmini Salgame. (2012) ‘Coinfection-helminthes and tuberculosis’. Current Opinion in HIV and AIDS 7:3, pages 239-244.
Crossref
Crossref
Steven C. Derrick, Dee Dao, Amy Yang, Kris Kolibab, William R. Jacobs & Sheldon L. Morris. (2012) Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against Tuberculosis. PLoS ONE 7:3, pages e32959.
Crossref
Crossref
Michael Favorov, Mohammad Ali, Aigul Tursunbayeva, Indira Aitmagambetova, Paul Kilgore, Shakhimurat Ismailov & Terence Chorba. (2012) Comparative Tuberculosis (TB) Prevention Effectiveness in Children of Bacillus Calmette-Guérin (BCG) Vaccines from Different Sources, Kazakhstan. PLoS ONE 7:3, pages e32567.
Crossref
Crossref
Wu Li, Guangcun Deng, Min Li, Xiaoming Liu & Yujiong Wang. (2012)
Roles of Mucosal Immunity against
Mycobacterium tuberculosis
Infection
. Tuberculosis Research and Treatment 2012, pages 1-12.
Crossref
Crossref
Uthaman Gowthaman, Vijender Singh, Weiguang Zeng, Shweta Jain, Kaneez F. Siddiqui, Sathi Babu Chodisetti, Rama Krishna Gurram, Pankaj Parihar, Pushpa Gupta, Umesh D. Gupta, David C. Jackson & Javed N. Agrewala. (2011) Promiscuous Peptide of 16 kDa Antigen Linked to Pam2Cys Protects Against Mycobacterium tuberculosis by Evoking Enduring Memory T-Cell Response. The Journal of Infectious Diseases 204:9, pages 1328-1338.
Crossref
Crossref
Walid Ben-Selma, Imen Ben-Kahla, Jalel Boukadida & Hedi Harizi. (2011)
Contribution of the
P2X7
1513A/C loss-of-function polymorphism to extrapulmonary tuberculosis susceptibility in Tunisian populations
. FEMS Immunology & Medical Microbiology 63:1, pages 65-72.
Crossref
Crossref
Vijender Singh, Shweta Jain, Uthaman Gowthaman, Pankaj Parihar, Pushpa Gupta, Umesh D. Gupta & Javed N. Agrewala. (2011) Co-Administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis Infected Macrophages Vaccine Induces Better Protective T Cell Memory than BCG. PLoS ONE 6:1, pages e16097.
Crossref
Crossref
Grace E. Marx & Edward D. Chan. (2011) Tuberculous Meningitis: Diagnosis and Treatment Overview. Tuberculosis Research and Treatment 2011, pages 1-9.
Crossref
Crossref
Gordon Dougan, David Goulding & Lindsay J. Hall. 2011. Replicating Vaccines. Replicating Vaccines
3
14
.
Keertan DHEDA, Stephan K. SCHWANDER, Bingdong ZHU, Richard N. Van ZYL‐SMIT & Ying ZHANG. (2010) The immunology of tuberculosis: From bench to bedside. Respirology 15:3, pages 433-450.
Crossref
Crossref
James P. Nataro & Myron M. Levine. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Guglielmo Lucchese, Angela Stufano & Darja Kanduc. (2010)
Proposing Low-Similarity Peptide Vaccines against
Mycobacterium tuberculosis
. Journal of Biomedicine and Biotechnology 2010, pages 1-8.
Crossref
Crossref
Shen-An Hwang, Ranjana Arora, Marian L. Kruzel & Jeffrey K. Actor. (2009) Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c). Tuberculosis 89, pages S49-S54.
Crossref
Crossref
Marcela Parra, Amy L. Yang, JaeHyun Lim, Kristopher Kolibab, Steven Derrick, Nathalie Cadieux, Liyanage P. Perera, William R. Jacobs, Michael Brennan & Sheldon L. Morris. (2009)
Development of a Murine Mycobacterial Growth Inhibition Assay for Evaluating Vaccines against
Mycobacterium tuberculosis
. Clinical and Vaccine Immunology 16:7, pages 1025-1032.
Crossref
Crossref
Peiying Ho, Lin Zhang, Xing Wei & Geok Teng Seah. (2009)
Mycobacterium chelonae
sensitisation induces CD4
+
‐mediated cytotoxicity against BCG
. European Journal of Immunology 39:7, pages 1841-1849.
Crossref
Crossref
Crystal Y. Chen, Dan Huang, Richard C. Wang, Ling Shen, Gucheng Zeng, Shuyun Yao, Yun Shen, Lisa Halliday, Jeff Fortman, Milton McAllister, Jim Estep, Robert Hunt, Daphne Vasconcelos, George Du, Steven A. Porcelli, Michelle H. Larsen, William R. Jacobs, Barton F. Haynes, Norman L. Letvin & Zheng W. Chen. (2009) A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis. PLoS Pathogens 5:4, pages e1000392.
Crossref
Crossref
Jong-Hyun Kim. (2009) Treatment of latent tuberculous infection in children and adolescent. Korean Journal of Pediatrics 52:5, pages 519.
Crossref
Crossref
Rhea N. Coler, Davin C. Dillon, Yasir A.W. Skeiky, Maria Kahn, Ian M. Orme, Yves Lobet, Steven G. Reed & Mark R. Alderson. (2009) Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloning. Vaccine 27:2, pages 223-233.
Crossref
Crossref
Edgar Badell, Fabienne Nicolle, Simon Clark, Laleh Majlessi, Frédéric Boudou, Angelo Martino, Luiz Castello-Branco, Claude Leclerc, David J.M. Lewis, Philip D. Marsh, Brigitte Gicquel & Nathalie Winter. (2009) Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-γ producing T-cells. Vaccine 27:1, pages 28-37.
Crossref
Crossref
Dominik Strapagiel, Karolina Kasztalska, Magdalena Druszczyńska, Magdalena Kowalewicz-Kulbat, Adriana Vrba, Agnieszka Matusiak, Magdalena Chmiela & Wiesława Rudnicka. (2008) Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.. Folia Histochemica et Cytobiologica 46:3.
Crossref
Crossref
Michael V. Tullius, Günter Harth, Saša Masleša-Galić, Barbara J. Dillon & Marcus A. Horwitz. (2008)
A Replication-Limited Recombinant
Mycobacterium bovis
BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
. Infection and Immunity 76:11, pages 5200-5214.
Crossref
Crossref
Bo Young Jeon, Steven C. Derrick, JaeHyun Lim, Kristopher Kolibab, Veerabadran Dheenadhayalan, Amy Li Yang, Barry Kreiswirth & Sheldon L. Morris. (2008)
Mycobacterium bovis
BCG Immunization Induces Protective Immunity against Nine Different
Mycobacterium tuberculosis
Strains in Mice
. Infection and Immunity 76:11, pages 5173-5180.
Crossref
Crossref
Bryce M. Buddle, Michel Denis, Frank E. Aldwell, H. Martin Vordermeier, R. Glyn Hewinson & D. Neil Wedlock. (2008) Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes. Tuberculosis 88:6, pages 595-600.
Crossref
Crossref
Zaida Araujo, Jacobus Henri de Waard, Carlos Fernández de Larrea, Rafael Borges & Jacinto Convit. (2008) The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Vaccine 26:44, pages 5575-5581.
Crossref
Crossref
Muralidhar K. Katti, Guixiang Dai, Lisa Y. Armitige, Carlos Rivera Marrero, Sundarsingh Daniel, Christopher R. Singh, Devin R. Lindsey, Subramanian Dhandayuthapani, Robert L. Hunter & Chinnaswamy Jagannath. (2008) The ΔfbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells. Cellular Microbiology 10:6, pages 1286-1303.
Crossref
Crossref
May Young Lin & Tom H.M. Ottenhoff. (2008)
Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent
Mycobacterium tuberculosis
infection
. bchm 389:5, pages 497-511.
Crossref
Crossref
D. Neil Wedlock, Michel Denis, Gavin F. Painter, Gary D. Ainge, H. Martin Vordermeier, R. Glyn Hewinson & Bryce M. Buddle. (2008)
Enhanced Protection against Bovine Tuberculosis after Coadministration of
Mycobacterium bovis
BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone
. Clinical and Vaccine Immunology 15:5, pages 765-772.
Crossref
Crossref
K. Katoch, Padam Singh, T. Adhikari, S.K. Benara, H.B. Singh, D.S. Chauhan, V.D. Sharma, M. Lavania, A.S. Sachan & V.M. Katoch. (2008) Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis. Vaccine 26:9, pages 1228-1234.
Crossref
Crossref
Kim Connelly Smith, Ian M. Orme & Jeffrey R. Starke. 2008. Vaccines. Vaccines
857
885
.
William R. Berrington & Thomas R. Hawn. (2007)
Mycobacterium tuberculosis
, macrophages, and the innate immune response: does common variation matter?
. Immunological Reviews 219:1, pages 167-186.
Crossref
Crossref
Hans-Willi Mittrücker, Ulrich Steinhoff, Anne Köhler, Marion Krause, Doris Lazar, Peggy Mex, Delia Miekley & Stefan H. E. Kaufmann. (2007) Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proceedings of the National Academy of Sciences 104:30, pages 12434-12439.
Crossref
Crossref
B. J. Marais, S. M. Graham, M. F. Cotton & N. Beyers. (2007) Diagnostic and Management Challenges for Childhood Tuberculosis in the Era of HIV. The Journal of Infectious Diseases 196:s1, pages S76-S85.
Crossref
Crossref
D. Neil Wedlock, Michel Denis, H. Martin Vordermeier, R. Glyn Hewinson & Bryce M. Buddle. (2007) Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNγ post-vaccination, but induce similar levels of protection against bovine tuberculosis. Veterinary Immunology and Immunopathology 118:1-2, pages 50-58.
Crossref
Crossref
Liana Tsenova, Ryhor Harbacheuski, Nackmoon Sung, Evette Ellison, Dorothy Fallows & Gilla Kaplan. (2007) BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25:28, pages 5126-5132.
Crossref
Crossref
Vasily Sosunov, Vladimir Mischenko, Boris Eruslanov, Edward Svetoch, Yulia Shakina, Norman Stern, Konstantin Majorov, Galina Sorokoumova, Alla Selishcheva & Alexander Apt. (2007) Antimycobacterial activity of bacteriocins and their complexes with liposomes. Journal of Antimicrobial Chemotherapy 59:5, pages 919-925.
Crossref
Crossref
Claire Swetman Andersen, Jes Dietrich, Else Marie Agger, Nils Y. Lycke, Karin Lövgren & Peter Andersen. (2007)
The Combined CTA1-DD/ISCOMs Vector Is an Effective Intranasal Adjuvant for Boosting Prior
Mycobacterium bovis
BCG Immunity to
Mycobacterium tuberculosis
. Infection and Immunity 75:1, pages 408-416.
Crossref
Crossref
D. ELIAS, H. AKUFFO & S. BRITTON. (2006) Helminthes could influence the outcome of vaccines against TB in the tropics. Parasite Immunology 28:10, pages 507-513.
Crossref
Crossref
David K Flaherty, Bridget Vesosky, Gillian L Beamer, Paul Stromberg & Joanne Turner. (2006)
Exposure to
Mycobacterium avium
can modulate established immunity against
Mycobacterium tuberculosis
infection generated by
Mycobacterium bovis
BCG vaccination
. Journal of Leukocyte Biology 80:6, pages 1262-1271.
Crossref
Crossref
Ben J. Marais, Robert P. Gie, H. Simon Schaaf, Nulda Beyers, Peter R. Donald & Jeff R. Starke. (2006) Childhood Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine 173:10, pages 1078-1090.
Crossref
Crossref
Liana Tsenova, Ryhor Harbacheuski, Andre L. Moreira, Evette Ellison, Wilfried Dalemans, Mark R. Alderson, Barun Mathema, Steven G. Reed, Yasir A. W. Skeiky & Gilla Kaplan. (2006) Evaluation of the Mtb72F Polyprotein Vaccine in a Rabbit Model of Tuberculous Meningitis. Infection and Immunity 74:4, pages 2392-2401.
Crossref
Crossref
D. M. Scollard, L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman & D. L. Williams. (2006) The Continuing Challenges of Leprosy. Clinical Microbiology Reviews 19:2, pages 338-381.
Crossref
Crossref
Antonia Isabel Castillo-RodalMauricio Castañón-ArreolaRogelio Hernández-PandoJuan José CalvaEduardo Sada-Díaz & Yolanda López-Vidal. (2006)
Mycobacterium bovis
BCG Substrains Confer Different Levels of Protection against
Mycobacterium tuberculosis
Infection in a BALB/c Model of Progressive Pulmonary Tuberculosis
. Infection and Immunity 74:3, pages 1718-1724.
Crossref
Crossref
Randall J. Basaraba, Angelo A. Izzo, Lise Brandt & Ian M. Orme. (2006) Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations. Vaccine 24:3, pages 280-286.
Crossref
Crossref
. (2005) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States. American Journal of Respiratory and Critical Care Medicine 172:9, pages 1169-1227.
Crossref
Crossref
Steven C. Derrick, Amy Li Yang & Sheldon L. Morris. (2005)
Vaccination with a Sindbis Virus-Based DNA Vaccine Expressing Antigen 85B Induces Protective Immunity against
Mycobacterium tuberculosis
. Infection and Immunity 73:11, pages 7727-7735.
Crossref
Crossref
Chen-Yuan Chiang & Lee W Riley. (2005) Exogenous reinfection in tuberculosis. The Lancet Infectious Diseases 5:10, pages 629-636.
Crossref
Crossref
Khaled S. Tabbara, Nathan C. Peters, Farhat Afrin, Susana Mendez, Sylvie Bertholet, Yasmine Belkaid & David L. Sacks. (2005)
Conditions Influencing the Efficacy of Vaccination with Live Organisms against
Leishmania major
Infection
. Infection and Immunity 73:8, pages 4714-4722.
Crossref
Crossref
Yasir A.W. Skeiky, Mark R. Alderson, Pamela J. Ovendale, Yves Lobet, Wilfried Dalemans, Ian M. Orme, Steven G. Reed & Antonio Campos-Neto. (2005) Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41. Vaccine 23:30, pages 3937-3945.
Crossref
Crossref
Timo Ulrichs, Claire Fieschi, Eva Nevicka, Helmut Hahn, Martin Brezina, Stefan H. E. Kaufmann, Jean-Laurent Casanova & Klara Frecerova. (2005) Variable outcome of experimental interferon-? therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12R?1-deficient Slovakian children. European Journal of Pediatrics 164:3, pages 166-172.
Crossref
Crossref
T.V. Radaeva, B.V. Nikonenko, V.V. Mischenko, M.M. AverbakhJr.Jr. & A.S. Apt. (2005) Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice. Tuberculosis 85:1-2, pages 65-72.
Crossref
Crossref
Michael J. Brennan. (2005) The tuberculosis vaccine challenge. Tuberculosis 85:1-2, pages 7-12.
Crossref
Crossref
Robert H. Copenhaver, Eliud Sepulveda, Lisa Y. Armitige, Jeffrey K. Actor, Audrey Wanger, Steven J. Norris, Robert L. Hunter & Chinnaswamy Jagannath. (2004)
A Mutant of
Mycobacterium tuberculosis
H37Rv That Lacks Expression of Antigen 85A Is Attenuated in Mice but Retains Vaccinogenic Potential
. Infection and Immunity 72:12, pages 7084-7095.
Crossref
Crossref
Steven C. Derrick, Amy Li Yang & Sheldon L. Morris. (2004) A polyvalent DNA vaccine expressing an ESAT6–Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23:6, pages 780-788.
Crossref
Crossref
SK Obaro, D Pugatch & K Luzuriaga. (2004) Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The Lancet Infectious Diseases 4:8, pages 510-518.
Crossref
Crossref
L. Holten-Andersen, T. M. Doherty, K. S. Korsholm & P. Andersen. (2004) Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines. Infection and Immunity 72:3, pages 1608-1617.
Crossref
Crossref
Suzanne M Hingley-Wilson, Vasan K Sambandamurthy & William R JacobsJrJr. (2003) Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nature Immunology 4:10, pages 949-955.
Crossref
Crossref
Guido Dietrich, Jean-Francois Viret & Jürgen Hess. (2003) Novel vaccination strategies based on recombinant Mycobacterium bovis BCG. International Journal of Medical Microbiology 292:7-8, pages 441-451.
Crossref
Crossref
DOUGLAS B. YOUNG. 2003. The Vaccine Book. The Vaccine Book
279
289
.
Tanya Parish & Neil G. Stoker. (2002) The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 148:10, pages 3069-3077.
Crossref
Crossref
John M Grange, John L Stanford & Cynthia A Stanford. (2017) Campbell De Morgan's ‘Observations on Cancer’, and their Relevance Today. Journal of the Royal Society of Medicine 95:6, pages 296-299.
Crossref
Crossref
T. Mark Doherty & Peter Andersen. (2002) Tuberculosis vaccine development. Current Opinion in Pulmonary Medicine 8:3, pages 183-187.
Crossref
Crossref